HERANTIS PHARMA OYJ
502098-0412ActiveDeveloping disease-modifying therapies for Parkinson's disease progression.
Clinical-Stage Biotechnology Companyherantis.com
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2025
- Perustettu
Kuvaus
Herantis Pharma Plc is a clinical-stage biotechnology company dedicated to addressing the unmet medical need in neurodegenerative diseases. Their primary focus is developing disease-modifying therapies aimed at stopping or reversing disease progression, specifically targeting Parkinson's disease. Th...
Tunnisteet
B2BHealthcarePharmaceuticalsPublicly Listed
Avainsanat
BiotechnologyClinical TrialsHER-096
Polku Therapeutics Oy